Chi Sheng Pharma & Biotech Co., Ltd
4111
Rank in Stocks
#22596
Chi Sheng Pharma & Biotech Co., Ltd. is a Taiwan-based company actively engaged... Chi Sheng Pharma & Biotech Co., Ltd. is a Taiwan-based company actively engaged in the development, production, distribution, and international trade of a diverse range of products. Operating across both domestic and global markets, the company specializes in pharmaceuticals, medical products, cosmetics, health foods, and medical equipment. Its extensive product portfolio covers numerous therapeutic categories, including antibiotics, chemotherapeutic agents, plasma substitutes, amino acid preparations, water nutrients, electrolyte solutions, and vitamins. Additionally, the company provides hepatotropic agents, hormones, adrenal cortical steroids, autonomic nerve agents, antihistamines, antipruritics, antipyretics, analgesics, antitussives, anti-asthmatics, gastro-intestinal preparations, and local anesthetic solutions. Further extending its offerings, Chi Sheng Pharma & Biotech supplies hemodialysis concentrates, peritoneal dialysis solutions, and various other specialized medical items. Beyond medicinal products, the company provides medical devices, fat emulsion products, anesthetics, hemostatic solutions, food products, functional beverages, skincare items, and veterinary medicines. It also offers external solutions such as those for contact lenses, saline, and iodine. The company was founded in 1962 and maintains its headquarters in Hsinchu, Taiwan.
Share Price
$0.86575863
Last synced: 2026-11-10
Market Cap
$51.80M
Change (1 day)
-0.18%
Change (1 year)
-10.85%
Country
Stock data: Financial Modeling PrepΒ·Updated Β·Not investment adviceΒ·How we calculate this
Trade Chi Sheng Pharma & Biotech Co., Ltd (4111)
Category
Healthcare
EPS for Chi Sheng Pharma & Biotech Co., Ltd (4111)
EPS as of June 2026 TTM: $0.10
According to Chi Sheng Pharma & Biotech Co., Ltd's latest financial reports, its current EPS (TTM) is $0.10. At the end of 2025 the company had an EPS of $0.09, an increase over its 2024 EPS of $0.06.
EPS history for Chi Sheng Pharma & Biotech Co., Ltd from 2019 to 2026
EPS at the end of each year
| Year | EPS | Change |
|---|---|---|
| 2026 (TTM) | $0.10 | 8.00% |
| 2025 | $0.09 | 48.22% |
| 2024 | $0.06 | 50.00% |
| 2023 | $0.04 | -55.28% |
| 2022 | $0.09 | 72.07% |
| 2021 | $0.05 | 38.38% |
| 2020 | $0.04 | -12.94% |
| 2019 | $0.04 | 0.00% |
EPS for similar companies or competitors
| Company | EPS | EPS Difference | Country |
|---|---|---|---|
| $8.37 | 8,511.11% |
US
|
|
| $6.02 | 6,095.37% |
FR
|
|
| $4.15 | 4,169.55% |
US
|
|
| $5.32 | 5,373.35% |
JP
|
|
| $1.29 | 1,227.16% |
CH
|
Questions about Chi Sheng Pharma & Biotech Co., Ltd's earnings per share (EPS)
What is Chi Sheng Pharma & Biotech Co., Ltd's earnings per share (EPS)?
Chi Sheng Pharma & Biotech Co., Ltd's earnings per share (EPS) over the last twelve months is $0.10, as of Jun 2026.
What was Chi Sheng Pharma & Biotech Co., Ltd's earnings per share (EPS) in 2025?
In 2025, Chi Sheng Pharma & Biotech Co., Ltd's earnings per share (EPS) was $0.09, 50.00% more than in 2024 ($0.06).
How has Chi Sheng Pharma & Biotech Co., Ltd's earnings per share (EPS) changed since 2020?
From 2020 to 2025, Chi Sheng Pharma & Biotech Co., Ltd's earnings per share (EPS) went from $0.04 to $0.09, an average growth of 17.61% a year.
How does Chi Sheng Pharma & Biotech Co., Ltd's earnings per share (EPS) compare with similar companies?
Chi Sheng Pharma & Biotech Co., Ltd's earnings per share (EPS) ($0.10) is lower than that of all 5 similar companies listed above. The highest among them is Intuitive Surgical, Inc., with $8.37.